Across TCGA pan-cancer cohorts, MIR302C RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR302C’s most consistent transcriptional readouts.

The strongest signal is observed in rectum adenocarcinoma (READ), where MIR302C RNA is repressed in tumor relative to normal tissue. In most cancer types MIR302C is over-expressed in tumor, although a few such as READ show the opposite, repressed pattern.

READ, KIRC, and ESCA are the cancer types where MIR302C tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR302C RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
READ	All	III,IV	−0.915	.018	2	view →
KIRC	Male	All	+0.198	.004	2	view →
ESCA	Male	All	+1.172	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MIR302C RNA expression & survival · all MIR302C data types